BrightGene Bio-Medical Technology Co. Ltd.SSE: 688166

Earnings Preannouncement for 2025

Jan 31, 2026 · Issued by BrightGene Bio-Medical Technology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 31, 2026

On 6ix: 6ix.com/news/earnings-preannouncement-for-2025-263

Earnings Preannouncement for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

BrightGene Bio-Medical Technology Co. Ltd. on 6ix

Earlier from BrightGene Bio-Medical Technology

Announcement on Not Redeeming ""BrightGene Convertible Bonds"" in AdvanceJan 6
Announcement on Postponing Investment Projects Financed by Raised FundsDec 31, 2025
Announcement on Interest Payment for "BrightGene Convertible Bonds" in 2025Dec 26, 2025
Announcement on Implementation Result of Shares Repurchase and Share ChangesDec 16, 2025
Announcement on Progress in Repurchasing SharesDec 2, 2025

Later from BrightGene Bio-Medical Technology

Announcement on Voluntary Disclosure of the Proposed Selection of Partial Products in the National Continuation Drug ProcurementFeb 12
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Outward Investment and Related Party TransactionsMar 11
2025 Annual ReportMar 20
Announcement on Convening the 2025 Annual Performance BriefingMar 25

All BrightGene Bio-Medical Technology news releases

Follow BrightGene Bio-Medical Technology into a list and get an email when it puts out news.

Follow BrightGene Bio-Medical Technology